perindoprilat

angiotensin I converting enzyme ; Homo sapiens







34 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 21411099 Hepatocyte growth factor promotes an anti-inflammatory cytokine profile in human abdominal aortic aneurysm tissue. 2011 Jun 2
2 18156630 Perindoprilat modulates the activity of lipoprotein receptor-related protein in human mesangial cells. 2008 Feb 22 1
3 18399693 Accurate aqueous proton dissociation constants calculations for selected angiotensin-converting enzyme inhibitors. 2008 Jun 1
4 16451098 Perindopril: a review of its use in patients with or at risk of developing coronary artery disease. 2006 1
5 14615289 Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells. 2004 Jan 9 3
6 14658015 Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition. 2004 Mar 1
7 12808303 Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis. 2003 Jun 2
8 12076191 Perindopril: in congestive heart failure. 2002 1
9 11398915 Perindopril: an updated review of its use in hypertension. 2001 2
10 11591356 Dosage considerations with perindopril for systemic hypertension. 2001 Oct 4 1
11 10904025 Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. 2000 Jul 2
12 9264500 ACE inhibition: postsynaptic adrenergic sympatholytic action in men. 1997 Aug 5 1
13 8989118 Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. 1996 Dec 15 1
14 8572858 [Restoration of normal coronary vasomotricity after intravenous infusion of angiotensin converting-enzyme inhibitor (perindoprilat) in hypertensive patients]. 1995 Aug 1
15 8070497 OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure. 1994 1
16 8249053 Enzyme immunoassays for a new angiotensin-converting enzyme inhibitor, zabicipril, and its active metabolite in human plasma: application to pharmacokinetic studies. 1993 Oct 2
17 1327596 Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril. 1992 3
18 1330941 Specific and high affinity binding of perindoprilat, but not of perindopril to blood ACE. 1992 Sep 1
19 1576057 The pharmacokinetics of perindopril in patients with liver cirrhosis. 1992 Mar 1
20 1657092 Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency. 1991 Aug 1
21 1657093 Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man. 1991 Aug 2
22 1718688 Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders. 1991 Jul 1
23 1817672 A new radioimmunoassay for the determination of the angiotensin-converting enzyme inhibitor perindopril and its active metabolite in plasma and urine: advantages of a lysine derivative as immunogen to improve the assay specificity. 1991 2
24 2088853 Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors. 1990 Dec 1
25 2172371 Vascular effects of intravenous infusion of the angiotensin converting enzyme inhibitor perindoprilat. 1990 Sep 3
26 2231339 Radioimmunoassay of a new angiotensin-converting enzyme inhibitor (perindopril) in human plasma and urine: advantages of coupling anion-exchange column chromatography with radioimmunoassay. 1990 Aug 2
27 2311339 Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum. 1990 Mar 1
28 2351367 Pharmacokinetics of perindopril and its metabolites in healthy volunteers. 1990 1
29 2407493 Perindopril. A review of its pharmacokinetics and clinical pharmacology. 1990 1
30 2505711 Pharmacokinetics of perindopril: therapeutic consequences. 1989 May 2
31 2550045 The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis. 1989 Jul 1
32 2559190 Pharmacokinetics of an ACE inhibitor, S-9780, in man: evidence of tissue binding. 1989 Oct 2
33 2605799 Pharmacokinetics of perindopril: therapeutic consequences. 1989 2
34 2844467 Influence of age on the pharmacokinetics and pharmacodynamics of perindopril. 1988 Oct 1